CVS Health Corp (NYSE:CVS) (TREND ANALYSIS) shares were traded with thin volume. The stock closed last trading session at $103.95, up by 0.25%, with a volume of 3,671,388 shares against an average volume for the last 3 months of 4,386,610.
Stock Performance: Click here for a free comprehensive Trend Analysis Report
CVS Health Corp (NYSE:CVS) is currently trading 1.43% below its 52-week-high, 39.27% above its 52-week-low. The 1-year range for the stock is $74.64 – $105.46. CVS Health Corp (CVS) has a price to earnings ratio of 25.48 versus Healthcare sector average of 42.53. CVS stock price has outperformed the S&P 500 by 5.1%. The Retail Drug Store company is currently valued at $117.15 billion and its share price closed the last trading session at $103.95. The stock has a 50-day moving average of $101.41 and a 200-day moving average of $98.37.
CVS Health Corp (CVS) current short interest stands at 10.08 million shares. It has decreased by 4% from the same period of last month. Around 1% of the company’s shares, which are float, are short sold. With a 10-days average volume of 4.08 million shares, the number of days required to cover the short positions stand at 2.5 days.
CVS reported last quarter earnings on May 01. The Retail Drug Store company announced earnings per share of $1.14 against a consensus Street estimate of $1.08, beating the average estimate by $0.06. This corresponds to a decrease of $0.03 compared to the same quarter of the previous fiscal year.
Is this a Buying Opportunity? Click here for a free Trend Analysis Report
There are currently twenty-five analysts that cover CVS stock. Of those twenty-five, twenty-two have a Buy rating, three have a Hold rating. On a consensus basis this yields to a Buy rating. The consensus target price stands at $113.86.
A recent analyst activity consisted of Jefferies reiterating their Buy stance on April 27. Jefferies increased their price target on CVS from $115 to $120. This corresponds to a 15.44% upside from the last closing price. On the date of report, the stock closed at $101.22.
Deutsche Bank reiterated their Hold stance on February 13, and increased their price target on CVS stock from $100 to $109. This corresponds to a 4.86% upside from the last closing price. On the date of report, the stock closed at $102.28.
Another research firm was Citigroup who reiterated their Neutral stance on February 13. Citigroup increased their price target on CVS Health Corp from $102 to $110. This translates to a 5.82% upside from the last closing price. On the date of report, the stock closed at $102.28.
CVS Health Corporation is an integrated pharmacy health care provider. The Company’s offerings include pharmacy benefit management services; mail order, retail and specialty pharmacy; disease management programs; and retail clinics. The company operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico.